NEW! EDI™ Novel Coronavirus COVID-19 ELISA Kits

Enzyme Linked Immunosorbent Assays (ELISA) for the qualitative detection of IgM or IgG and the quantitative detection of IgG.

KT-1032 KT-1033 KT-1034

Overview  //  Technical Specifications  //  Protocols //  Instructions for Use 

Overview

 The 2019 Novel Coronavirus (COVID-19) is a single-stranded RNA coronavirus. Comparisons of the genetic sequences of this virus have shown 

similarities to SARS-CoV and other bat coronaviruses. In humans, coronaviruses cause respiratory infections.  Coronaviruses are composed of several 

proteins including the spike (S), envelope (E), membrane (M), and nucleocapsid (N). It has been suggested that the spike protein has sufficient affinity 

to the angiotensin converting enzyme 2 (ACE2) receptor to use it as a mechanism of cell entry. Human-to-human transmission of coronaviruses is primarily 

thought to occur among close contacts via respiratory droplets generated by sneezing and coughing. 

There are over 90,000 confirmed Coronavirus cases globally with over 3,000 deaths as a direct result of the infection.

Effective detection of the coronavirus is extremely critical. Currently, real-time polymerase chain reaction (RT-PCR) tests detect genetic material 

to perform coronavirus testing. However, these tests have low rates of specificity and sensitivity and pose risks related to specimen collection and

sample handling. Epitope Diagnostics, Inc. has developed a solution to minimize these risks by using IgG and IgM ELISA kits. IgG is the most abundant

immunoglobulin to be produced in response to an antigen and is maintained in the body after initial exposure for long term response. 

IgM is the first immunoglobulin to be produced in response to an antigen and is primarily detected during the early onset of disease.

• - It reports the COVID-19 IgG concentrations than just OD levels. For multiple serum samples drawn and tested in different dates from
•  each individual patient, the COVID-19 IgG concentration would be very comparable for trending/monitoring the immune response. 

• - It becomes possible in standardize the COVID-19 IgG measurement.

• - It makes the convalescent plasma donor qualification much easier to be qualified with the COVID-19 IgG concentration.
•  

Technical Specifications